Methods for decreasing pigment particles in the anterior chamber in exfoliation syndrome and pigment dispersion syndrome. BY WISAM SHIHADEH, MD, AND ROBERT RITCH, MD
نویسندگان
چکیده
EXFOLIATION SYNDROME Overview Exfoliation syndrome is the most widespread, classifiable cause of open-angle glaucoma worldwide.1 In this age-related disorder, fibrillar extracellular materials are produced by and accumulate in various ocular tissues (Figure 1). Friction between the anterior lens capsule and the iris disrupts the iris pigment epithelium, dispersing pigment throughout the anterior chamber. The result is corneal pigmentation, iris sphincter transillumination defects (Figure 2), and a characteristic increase in the trabecular meshwork’s pigment (Figure 3). Pigment dispersion may occur before the physician even detects exfoliation syndrome with a slitlamp examination.2 The release of pigment into the anterior chamber is common and profuse after pupillary dilation in patients with exfoliation syndrome.3-8 Subsequent increases in IOP can be as high as 30 mm Hg above baseline and may peak as many as 2 or 3 hours after dilation.9 It is particularly important for physicians to measure IOP and assess the degree of pigment release in the anterior chamber after pupillary dilation. If the spread of pigment is extensive, the clinician should continue follow-up until the patient’s IOP is safely under control. Unrecognized pressure spikes may exacerbate glaucomatous damage, particularly in patients whose disease is moderate to severe. We have seen a patient with exfoliative glaucoma who suffered a central retinal vein occlusion and an IOP spike to 55 mm Hg after pupillary dilation.
منابع مشابه
A comparison of functional and structural measures for identifying progression of glaucoma.
PURPOSE To compare glaucoma progression by functional and structural tests. METHODS The authors prospectively studied 33 glaucoma patients (55 eyes); 20 eyes (15 patients) had disc hemorrhage, and 35 eyes (18 patients) had exfoliation glaucoma. The following tests were performed at two baseline and three follow-up examinations: frequency doubling perimetry (FDT), 24-2 Humphrey visual fields (...
متن کاملVorapaxar in Acute Coronary Syndrome Patients Undergoing Coronary Artery Bypass Graft Surgery
Vorapaxar in Acute Coronary Syndrome Patients Undergoing Coronary Artery Bypass Graft Surgery Subgroup Analysis From the TRACER Trial (Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome) David J. Whellan, MD,* Pierluigi Tricoci, MD, PHD,y Edmond Chen, MD,z Zhen Huang, MS,y David Leibowitz, MD,x Pascal Vranckx, MD,k Gregary D. Marhefka, MD,* Claes Held, MD, PHD,...
متن کاملValue of high-sensitivity troponin in assessing the extent of benefit provided by ticagrelor versus clopidogrel in non-ST-segment elevation acute coronary syndromes.
Biomarkers in Relation to the Effects of Ticagrelor in Comparison With Clopidogrel in Non–ST-Elevation Acute Coronary Syndrome Patients Managed With or Without In-Hospital Revascularization: A Substudy From the Prospective Randomized Platelet Inhibition and Patient Outcomes (PLATO) Trial Lars Wallentin, MD, PhD; Daniel Lindholm, MD; Agneta Siegbahn, MD, PhD; Lisa Wernroth, MSc; Richard C. Becke...
متن کاملClinical and Therapeutic Profile of Patients Presenting With Acute Coronary Syndromes Who Do Not Have Significant Coronary Artery Disease
Matthew T. Roe, MD; Robert A. Harrington, MD; Danielle M. Prosper, MS; Karen S. Pieper, MS; Deepak L. Bhatt, MD; A. Michael Lincoff, MD; Maarten L. Simoons, MD; Martijn Akkerhuis, MD; E. Magnus Ohman, MD; Michael M. Kitt, MD; Alec Vahanian, MD; Witold Ruzyllo, MD; Karl Karsch, MD; Robert M. Califf, MD; Eric J. Topol, MD; for the Platelet Glycoprotein IIb/IIIa in Unstable Angina: Receptor Suppre...
متن کاملPrognostic Value of ST Segment Depression in Acute Coronary Syndromes: Insights From PARAGON-A Applied to GUSTO-IIb
Padma Kaul, PHD,* Yuling Fu, MD,* Wei-Ching Chang, PHD,* Robert A. Harrington, MD,† Galen S. Wagner, MD,† Shaun G. Goodman, MD,‡ Christopher B. Granger, MD,† David J. Moliterno, MD,§ Frans Van de Werf, MD,\ Robert M. Califf, MD,† Eric J. Topol, MD,§ Paul W. Armstrong, MD,* for the PARAGON-A and GUSTO-IIb Investigators Edmonton, Alberta and Toronto, Ontario, Canada; Durham, North Carolina; Cleve...
متن کامل